160 related articles for article (PubMed ID: 9240444)
1. Effects of apo E deficiency on plasma lipid levels in mice lacking APOBEC-1.
Osuga J; Yagyu H; Ohashi K; Harada K; Yazaki Y; Yamada N; Ishibashi S
Biochem Biophys Res Commun; 1997 Jul; 236(2):375-8. PubMed ID: 9240444
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
[TBL] [Abstract][Full Text] [Related]
3. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.
Davidson NO
Ann Med; 1993 Dec; 25(6):539-43. PubMed ID: 8292303
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.
Hirano K; Young SG; Farese RV; Ng J; Sande E; Warburton C; Powell-Braxton LM; Davidson NO
J Biol Chem; 1996 Apr; 271(17):9887-90. PubMed ID: 8626621
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B mRNA editing is preserved in the intestine and liver of zinc-deficient rats.
Nassir F; Blanchard RK; Mazur A; Cousins RJ; Davidson NO
J Nutr; 1996 Apr; 126(4):860-4. PubMed ID: 8613888
[TBL] [Abstract][Full Text] [Related]
7. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
Greeve J; Axelos D; Welker S; Schipper M; Greten H
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
[TBL] [Abstract][Full Text] [Related]
8. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice.
Kendrick JS; Chan L; Higgins JA
Biochem J; 2001 Jun; 356(Pt 3):821-7. PubMed ID: 11389690
[TBL] [Abstract][Full Text] [Related]
9. Apobec-1 and apolipoprotein B mRNA editing.
Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
Mehta A; Kinter MT; Sherman NE; Driscoll DM
Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
[TBL] [Abstract][Full Text] [Related]
11. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
12. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
13. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B messenger RNA editing: an update.
Chan L
Biochimie; 1995; 77(1-2):75-8. PubMed ID: 7599279
[TBL] [Abstract][Full Text] [Related]
16. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
Mehta A; Driscoll DM
RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
[TBL] [Abstract][Full Text] [Related]
17. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
18. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.
Xie Y; Nassir F; Luo J; Buhman K; Davidson NO
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G735-46. PubMed ID: 12816761
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]